Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-14

Clinical Trial Update: Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating fluorouracil plus leucovorin with or without oxaliplatin in Stage II or Stage III colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eloxatin (oxaliplatin)
  • FLUOROURACIL (Fluorouracil)
  • Leucovorin (folinic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage II Colon Cancer, Stage III Colon Cancer | Phase 3 | Status: COMPLETED